Amie McNeice to lead marketing at Diaceutics on global expansion drive

By April Lara

April 11, 2024

McNeice has a track record in senior marketing and business development roles

Rapidly growing Belfast and London R&D diagnostics and precision medicine firm Diaceutics has appointed Amie McNeice as vice president of marketing to target US and European expansion. 

McNeice has a track record in senior marketing and business development roles at firms, including Almac Group, Fibrus, and Kingspan.

Strategic Focus on Client Empowerment and Market Expansion

In a recent trading update, Diaceutics announced a 22% increase in revenue, reaching £23.7m. Additionally, the company highlighted a 57% surge in its order book, now standing at £26.6m. 

Against this backdrop of financial growth, McNeice's appointment underscores Diaceutics' commitment to strengthening its presence in key US and European markets.

This move comes amidst Diaceutics' concerted efforts to enhance its sales and marketing capabilities. The company claims its mission is to empower pharmaceutical and biotech clients with data-driven insights and technology solutions to boost product commercialisation and improve patient outcomes.

Prepped for Team Expansion

In addition to McNeice's appointment, Diaceutics continues strengthening its product development efforts, with plans to expand its product management team in 2024. 

Tell us your appointment and promotions news.